Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlo Petakh

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 17, 2023
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metforminPavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
Frontiers in Cellular and Infection Microbiology|February 27, 2023
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based methodPavlo Petakh, Nazarii Kobyliak, Aleksandr Kamyshnyi
Frontiers in Pharmacology|April 3, 2025
Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint healthIryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi
Molecular Metabolism|September 11, 2023
Effects of metformin on the gut microbiota: A systematic reviewPavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
Plos Neglected Tropical Diseases|March 17, 2025
Prevalence of leptospirosis among soldiers: A systematic reviewPavlo Petakh, Valentyn Oksenych, Oleksandr Kamyshnyi
One Health (Amsterdam, Netherlands)|December 16, 2024
Geographical factors and air raid alarms influence leptospirosis epidemiology in Ukraine (2018-2023)Pavlo Petakh, Wolfgang Huber, Oleksandr Kamyshnyi
Inflammopharmacology|September 29, 2023
Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markersPavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
Frontiers in Endocrinology|November 21, 2024
Predictive analysis of osteoarthritis and chronic pancreatitis comorbidity: complications and risk factorsIryna Halabitska, Pavlo Petakh, Valentyn Oksenych, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific PatternsPavlo Petakh, Valentyn Oksenych, Yevheniya Khovpey, et al.
The FEBS Journal|July 13, 2025
A CRISPR-Cas9-based tool for dose-dependent DNA damage detectionValentyn Oksenych, Pavlo Petakh, Denis Kainov, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 17, 2023
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metforminPavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
Frontiers in Cellular and Infection Microbiology|February 27, 2023
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based methodPavlo Petakh, Nazarii Kobyliak, Aleksandr Kamyshnyi
Frontiers in Pharmacology|April 3, 2025
Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint healthIryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi
Molecular Metabolism|September 11, 2023
Effects of metformin on the gut microbiota: A systematic reviewPavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
Plos Neglected Tropical Diseases|March 17, 2025
Prevalence of leptospirosis among soldiers: A systematic reviewPavlo Petakh, Valentyn Oksenych, Oleksandr Kamyshnyi
One Health (Amsterdam, Netherlands)|December 16, 2024
Geographical factors and air raid alarms influence leptospirosis epidemiology in Ukraine (2018-2023)Pavlo Petakh, Wolfgang Huber, Oleksandr Kamyshnyi
Inflammopharmacology|September 29, 2023
Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markersPavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
Frontiers in Endocrinology|November 21, 2024
Predictive analysis of osteoarthritis and chronic pancreatitis comorbidity: complications and risk factorsIryna Halabitska, Pavlo Petakh, Valentyn Oksenych, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific PatternsPavlo Petakh, Valentyn Oksenych, Yevheniya Khovpey, et al.
The FEBS Journal|July 13, 2025
A CRISPR-Cas9-based tool for dose-dependent DNA damage detectionValentyn Oksenych, Pavlo Petakh, Denis Kainov, et al.
Pageof 7